Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole vs Amphotericin B/Fluconazole in Candidemia
NCT00163111Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 1998
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, open-label trial of voriconazole in candidemia (2 arms), sponsored by Pfizer. Primary endpoint: Sustained clinical response. Started Sep 1998; status: completed.
02
Drugs
voriconazole
03
Conditions
candidemia
Beyond the preview
Go deeper on NCT00163111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163111.